The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Official Title: Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel® Wafer (Carmustine Implant) Used in Usual Medical Practice
Study ID: NCT02684838
Brief Summary: This is a prospective, observational registry in patients who have been prescribed Gliadel Wafer by the physician as part of usual care.
Detailed Description: This is a prospective, observational registry in patients who have been prescribed Gliadel Wafer by the physician as part of usual care. Data will be collected on the safety and effectiveness of treatment with Gliadel Wafer perioperatively and ongoing during regular office visits up to 3-years. Patients enrolled in this registry will be asked to complete a questionnaire (Functional Assessment of Cancer Therapy-Brain \[FACT-Br\]) about their well-being and clinicians will complete the Karnofsky Performance Status (KPS) during office visits.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Spine and Neuro Center, Huntsville, Alabama, United States
Borrow Neurological Institute, Phoenix, Arizona, United States
Spine Group Arizona At Honorhealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States
Neurological Associates of Tucson, DBA Center for Neurosciences, Tucson, Arizona, United States
David Geffen School of Medicine at UCLA; Departments of Neurosurgery and Pathology at the, Los Angeles, California, United States
University of California, San Francisco Department of Neurological Surgery, San Francisco, California, United States
University of Colorado School of Medicine, Aurora, Colorado, United States
Baycare Medical Group, Tampa, Florida, United States
Emory University Hospital, Atlanta, Georgia, United States
Beacon Medical Group, Elkhart, Indiana, United States
Baptist Health Paducah, Paducah, Kentucky, United States
Oschner Medical Center, New Orleans, Louisiana, United States
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
McLaren Bay Neurology Associates, Bay City, Michigan, United States
Henry Ford Health System, Detroit, Michigan, United States
Depaul Hospital, Bridgeton, Missouri, United States
St. Louis University Hospital, Saint Louis, Missouri, United States
Western Regional Ctr for Brain and Spine Surgery, Las Vegas, Nevada, United States
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Jfk Medical Center, Edison, New Jersey, United States
Albany Medical Center Hospital, Albany, New York, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Brain Tumor Center, Lake Success, New York, United States
Crouse Neuroscience Institute, Syracuse, New York, United States
Vidant Medical Center, Greenville, North Carolina, United States
Wake Forest Baptist Med Center, Winston-Salem, North Carolina, United States
Mount Carmel Neurosurgery, Columbus, Ohio, United States
University of Oklahoma - Stevenson Cancer Center, Oklahoma City, Oklahoma, United States
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
Grand Strand Medical Center, Myrtle Beach, South Carolina, United States
University of Washington School of Medicine, Seattle, Washington, United States
Name: Evan Scullin, MD
Affiliation: Arbor Pharmaceuticals, LLC is a subsidiary of Azurity Pharmaceuticals, Inc."
Role: STUDY_CHAIR